Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;35(4):e15324.
doi: 10.1111/dth.15324. Epub 2022 Jan 30.

Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review

Maddalena Napolitano  1 , Mariateresa Nocerino  2 , Vincenzo Picone  2 , Fabrizio Martora  2 , Gabriella Fabbrocini  2 , Stefano Dastoli  3 , Cataldo Patruno  3
Affiliations
Review

Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review

Maddalena Napolitano et al. Dermatol Ther. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Gabriella Fabbrocini acted as a speaker or consultant for Abbvie, Amgen, Eli Lilly, Janssen, Leo‐Pharma, Almyrall, Novartis, and UCB. None of the contributing authors has any conflict of interest, including specific financial interests of relationships and affiliation relevant to the subject matter or discussed materials in the manuscript.

References

    1. Patruno C, Napolitano M, Argenziano G, et al. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study. J Eur Acad Dermatol Venereol. 2021;35(4):958‐964. - PubMed
    1. DUPIXENT (dupilumab) injection. Accessdata.fda.gov
    1. Kha C, Raji K, Chisolm S. Treatment of atopic dermatitis with dupilumab in a renal transplant patient. Dermatitis. 2020;31(2):e17‐e18. - PubMed
    1. Jamgochian M, Milgraum D, Milgraum S, Pappert A. Dupilumab as treatment for atopic dermatitis in a pediatric heart transplant patient: a case report. Dermatol Ther. 2020;33(6):e14018. - PubMed
    1. Ludriksone L, Elsner P, Malessa C, Settmacher U, Schliemann S. Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report. J Dtsch Dermatol Ges. 2020;18(7):740‐742. - PubMed

Substances